Progression of pancreatic neuroendocrine tumors (PanNETs) to metastatic disease is associated with MCT4 expression and metabolic heterogeneity

被引：0
|
作者：
Sadowski, M. [1 ]
Brautigam, K. [1 ]
Straub, J. [1 ]
Andreasi, V [2 ]
Kirchner, P. [1 ]
Maire, R. [1 ]
Dettmer, M. [1 ]
Schrader, J. [3 ]
Partelli, S. [2 ]
Falconi, M. [2 ]
Marinoni, I [1 ]
Perren, A. [1 ]
机构：
[1] Univ Bern, Bern, Switzerland
[2] Univ Vita Salute San Raffaele, Milan, Italy
[3] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2023年 / 35卷
关键词：
mct4; metabolic subtypes; aggressive pannet; patient-derived tumoroid;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F19
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [41] Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns
    Yu Jiang
    Yi-han Dong
    Shi-wei Zhao
    Dong-yu Liu
    Ji-yang Zhang
    Xiao-ya Xu
    Hao Chen
    Hao Chen
    Jia-bin Jin
    Cell Communication and Signaling, 22
  • [42] Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors
    Keutgen, Xavier M.
    Nilubol, Naris
    Glanville, Joanne
    Sadowski, Samira M.
    Liewehr, David J.
    Venzon, David J.
    Steinberg, Seth M.
    Kebebew, Electron
    SURGERY, 2016, 159 (01) : 311 - 318
  • [43] Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
    Singhi, Aatur D.
    Liu, Ta-Chiang
    Roncaioli, Justin L.
    Cao, Dengfeng
    Zeh, Herbert J.
    Zureikat, Amer H.
    Tsung, Allan
    Marsh, J. Wallis
    Lee, Kenneth K.
    Hogg, Melissa E.
    Bahary, Nathan
    Brand, Randall E.
    McGrath, Kevin M.
    Slivka, Adam
    Cressman, Kristi L.
    Fuhrer, Kimberly
    O'Sullivan, Roderick J.
    CLINICAL CANCER RESEARCH, 2017, 23 (02) : 600 - 609
  • [44] Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients With Pancreatic Neuroendocrine Tumors
    Singhi, A. D.
    Liu, T. -C.
    Roncaioli, J. L.
    Zeh, H. J.
    Zureikat, A. H.
    Tsung, A.
    Marsh, J. W.
    Lee, K. K.
    Hogg, M. E.
    Bahary, N.
    Brand, R. E.
    McGrath, K.
    Slivka, A.
    Cressman, K. L.
    Fuhrer, K.
    O'Sullivan, R. J.
    PANCREAS, 2016, 45 (10) : 1539 - 1539
  • [45] Alternative Lengthening of Telomeres Predicts Metastatic Disease and Poor Survival in Patients With Pancreatic Neuroendocrine Tumors
    Kinowaki, Y.
    Matsuda, Y.
    Fukumura, Y.
    Kudo, A.
    Akashi, T.
    Kitagawa, M.
    PANCREAS, 2019, 48 (10) : 1462 - 1462
  • [46] Do morphologic characteristics play a role in nodal metastatic progression of well-differentiated pancreatic neuroendocrine tumors?
    Ugras, Nesrin
    Hasdemir, Secil
    Yerci, Omer
    Tasar, Pinar
    Dundar, Halit Ziya
    Macunluoglu, Asli Ceren
    TUMORI JOURNAL, 2021, 107 (01): : 80 - 85
  • [47] Changes in gene expression in small bowel neuroendocrine tumors associated with progression to metastases Discussion
    Hughes, Mary Beth
    Keck, Kendall J.
    Fahey, Thomas, III
    Demeure, Michael
    SURGERY, 2018, 163 (01) : 239 - 239
  • [48] Evidence for a stromal-epithelial "lactate shuttle" in human tumors MCT4 is a marker of oxidative stress in cancer-associated fibroblasts
    Whitaker-Menezes, Diana
    Martinez-Outschoorn, Ubaldo E.
    Lin, Zhao
    Ertel, Adam
    Flomenberg, Neal
    Witkiewicz, Agnieszka K.
    Birbe, Ruth C.
    Howell, Anthony
    Pavlides, Stephanos
    Gandara, Ricardo
    Pestell, Richard G.
    Sotgia, Federica
    Philp, Nancy J.
    Lisanti, Michael P.
    CELL CYCLE, 2011, 10 (11) : 1772 - 1783
  • [49] Increased Claudin 4 Expression Is Associated with Aggressiveness of Pulmonary Neuroendocrine Tumors
    Li, J.
    Lu, S.
    Mangray, S.
    Aswad, B.
    Monahan, R.
    Noble, L.
    Resnick, M.
    Yakirevich, E.
    MODERN PATHOLOGY, 2013, 26 : 458A - 458A
  • [50] Sequential treatment in patients with metastatic pancreatic neuroendocrine tumors after progression on first-line therapy.
    Tsang, Erica S.
    Speers, Caroline
    Cheung, Winson Y.
    Kennecke, Hagen F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
12345